News | August 11, 2024
Merck inks MoU with Aragen to facilitate supply of equipment and technologies for mAb
This accelerates the clinical-to-commercial process timeline and enables customers to develop the right molecule
This accelerates the clinical-to-commercial process timeline and enables customers to develop the right molecule
The initiative aimed to reach and support individuals suffering from epilepsy through early detection and effective disease management
Strides’ approval for this product marks the 1st Indian approval from the USFDA for this complex formulation
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Executes the first project for developing and manufacturing a novel anticancer mAb
New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day
The company will be managing orders and warehouse operations for Little's, Lacto-calamine, Tri-activ, I-feel, Ourdaily, and Sloan's through the Unicommerce platform
The three-day event in Bengaluru was conducted in collaboration with the Karnataka Ophthalmology Society (KOS) and the Bangalore Ophthalmology Society (BOS)
The workshop was conducted as a part of the NITI–State workshop series
The primary goal of this joint venture is to develop and commercialise novel cell therapy products for major unmet medical needs in the United States, Japan, and EU regions
Subscribe To Our Newsletter & Stay Updated
